🇺🇸 FDA
Patent

US 7550617

Compositions and methods for the treatment of renal and cardiovascular disease

granted A61PA61P13/12A61P9/00

Quick answer

US patent 7550617 (Compositions and methods for the treatment of renal and cardiovascular disease) held by The Board of Regents of the University of Texas System expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61P, A61P13/12, A61P9/00